by Alamab | Oct 21, 2019 | ALMB-0166, Home Page
INVESTIGATIONAL NEW DRUG ALMB-0166GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA CSPC Pharmaceutical Group Limited 石 藥 集 團 有 限 公 司 (Incorporated in Hong Kong under the Companies Ordinance)(Stock Code: 1093) Hong Kong, 21 October 2019 The board of directors (the...
by Alamab | Aug 15, 2019 | ALMB-0166
SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0166 IN AUSTRALIA CSPC Pharmaceutical Group Limited 石 藥 集 團 有 限 公 司 (Incorporated in Hong Kong under the Companies Ordinance)(Stock Code: 1093) August 15, 2019 The Board of...
by Alamab | Nov 26, 2018 | ALMB-0166
ALMB-0166 was granted Orphan-Drug Designation by the U.S. FDA CSPC Pharmaceutical Group Limited 石 藥 集 團 有 限 公 司 (Incorporated in Hong Kong under the Companies Ordinance)(Stock Code: 1093) November 26, 2018 The board of directors (the “Board”) of CSPC Pharmaceutical...
